Metastatic Cervical Cancer Completed Phase 2 Trials for Lapatinib (DB01259)

Also known as: Metastatic Cervical Cancers / Cervical Cancer Metastatic

IndicationStatusPhase
DBCOND0036674 (Metastatic Cervical Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00430781Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical CancerTreatment